4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025500
Director sold 1,570 shares at an average $30.00 ($47,104)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-18 | Sale : show line 1 in the form 10b5-1 | −817 | $30.00 | $24,512 | 123,673 | D |
| 2024-10-18 | Sale : show line 2 in the form 10b5-1 | −753 | $30.00 | $22,592 | 27,165 | I |
| Open-market sales · 1,570 sh · avg $30.00 · $47,104 | ||||||
Loading xslF345X05/form4-10222024_081053.xml…